Growth Equity Opportunities Fund Iv, LLC is > 10% Shareholder of AVEO PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of AVEO, which is worth approximately $0. The most recent transaction as insider was on Oct 19, 2022, when has been sold 3,952,957 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Growth Equity Opportunities Fund IV, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2022
SELL
Other acquisition or disposition
-
3,952,957 Reduced 100.0%
0 Common Stock
GEO

Growth Equity Opportunities Fund Iv, LLC

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on AVEO

Follow AVEO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVEO shares.

Notify only if

Insider Trading

Get notified when an Aveo Pharmaceuticals, Inc. insider buys or sells AVEO shares.

Notify only if

News

Receive news related to AVEO PHARMACEUTICALS, INC.

Track Activities on AVEO